K2M Group Holdings Inc  

(Public, NASDAQ:KTWO)   Watch this stock  
Find more results for K2M, Inc
-0.84 (-4.38%)
After Hours: 18.32 0.00 (0.00%)
Oct 13, 4:41PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 18.20 - 19.75
52 week 13.70 - 26.29
Open 19.03
Vol / Avg. 204,135.00/186,419.00
Mkt cap 751.38M
P/E     -
Div/yield     -
EPS -1.26
Shares 41.34M
Beta     -
Inst. own 53%
Nov 3, 2015
Q3 2015 K2M Group Holdings Inc Earnings Call - 5:00PM EST - Add to calendar
Nov 3, 2015
Q3 2015 K2M Group Holdings Inc Earnings Release - 4:00PM EST - Add to calendar
Sep 16, 2015
K2M Group Holdings Inc at Morgan Stanley Healthcare Conference
Sep 9, 2015
K2M Group Holdings Inc at Wells Fargo Healthcare Conference
Aug 4, 2015
Q2 2015 K2M Group Holdings Inc Earnings Call
Aug 4, 2015
Q2 2015 K2M Group Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -11.04% -31.95%
Operating margin -15.32% -25.70%
EBITD margin - -7.85%
Return on average assets -7.62% -19.89%
Return on average equity -8.85% -29.92%
Employees 448 -
CDP Score - -


751 Miller Dr SE
LEESBURG, VA 20175-8993
United States - Map
+1-703-7773155 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


K2M Group Holdings, Inc. (KTWO) is a global medical device company focused on designing, developing and commercializing spine technologies and techniques. The Company's spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. The Company is engaged in the design, development and commercialization of a number of minimally invasive spine (MIS) products and products for patients suffering from degenerative spinal conditions. The Company's products consist of implants, disposables and instruments, which are marketed and sold primarily to hospitals for use by spine surgeons. The Company's technologies include MESA, Rail 4D, Deformity Cricket, CAPRI, SERENGETI, RAVINE, EVEREST and tifix. The Company offers products-based on its technologies for complex spine, minimally invasive spine and degenerative spine. The Company is engaged in product development activities for the spine and MIS markets.

Officers and directors

Daniel A. Pelak Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Eric D. Major President, Chief Executive Officer, Director
Age: 45
Bio & Compensation  - Reuters
Gregory S. Cole CPA Chief Financial Officer
Age: 44
Bio & Compensation  - Reuters
Kostuik P. John Chief Medical Officer, Director
Age: 77
Bio & Compensation  - Reuters
Brett P. Brodnax Director
Age: 50
Bio & Compensation  - Reuters
Carlos A. Ferrer Director
Age: 57
Bio & Compensation  - Reuters
Paul B. Queally Director
Age: 50
Bio & Compensation  - Reuters
Sean M. Traynor Director
Age: 46
Bio & Compensation  - Reuters
Michael A Turpin Director
Age: 53
Bio & Compensation  - Reuters